TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bohus BioTech AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
56,112
|
57,233
|
25,284 |
| Financial expenses |
3,529
|
51
|
1,471 |
| Earnings before taxes |
-48,364
|
47,831
|
-96,502 |
| EBITDA |
-43,792
|
49,072
|
-67,039 |
| Total assets |
119,507
|
62,968
|
55,429 |
| Current assets |
89,630
|
45,148
|
46,031 |
| Current liabilities |
16,317
|
19,521
|
56,038 |
| Equity capital |
34,366
|
42,739
|
-57,357 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) |
30
|
29
|
39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
28.8%
|
67.9%
|
-103.5% |
| Turnover per employee |
1,870
|
1,974
|
648 |
| Profit as a percentage of turnover |
-86.2%
|
83.6%
|
-381.7% |
| Return on assets (ROA) |
-37.5%
|
76.0%
|
-171.4% |
| Current ratio |
549.3%
|
231.3%
|
82.1% |
| Return on equity (ROE) |
-140.7%
|
111.9%
|
168.2% |
| Change turnover |
-1,121
|
31,949
|
-62,975 |
| Change turnover % |
-2%
|
126%
|
-71% |
| Chg. No. of employees |
1
|
-10
|
-10 |
| Chg. No. of employees % |
3%
|
-26%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.